Joined April 2023
- Tweets 631
- Following 34
- Followers 3,497
- Likes 473
131 Photos and videos
Jun 11
A new comment in Nature Portfolio by Drs. Sam Stevens and Deme Karikios discusses need to rigorously evaluate outcomes following the decision to allow tumour-agnostic immunotherapy reimbursement in Australia. This bold policy experiment broadens drug availability, but carries an obligation to learn about patient outcomes, quality use of medicines, equity of access and toxicities so that health systems can serve patients in a way that sensibly balances speed, access and certainty with the best available evidence.
doi.org/10.1038/s41571-026-0…
#CommonSenseOncology #CancerCare #Nivolumab #Ipilimumab #TumorAgnostic #PrecisionOncology
ALT Nature reviews clinical oncology. Realizing the benefits of tumour-agnostic access requires a national health learning system. An injection drug is siphoned out of its container using a needle.
3
186
Jun 10
Regístrate aquí: queensu.zoom.us/meeting/regi…
Common Sense Oncology in Iberoamerican Context:
Registration free:
commonsenseoncology.org/even…
3
4
275
Scientific innovations in the cancer care space are to be celebrated for the amazing possibilities they can provide. However, these advances can sometimes seem to exist in a separate world from the lives of the very people who are treated by them, their families and communities.
This year, ASCO was opened by an extraordinary plenary speech by Dr. Eric Small. In it, he highlighted gaps in the translation of healthcare innovations. Large gaps exist: in global and regional cancer care equity, in compassionate and accessible communications to patients from medical experts, and access to affordable and effective treatments.
People with lived cancer experience deserve outcomes that matter. As Dr. Small said: Every cancer. Every patient. Everywhere. While advances should be implemented, health care systems should also prioritize treatments that deliver meaningful benefits to patients.
Let's drive human-centred progress in oncology together.
#CommonSenseOncology #CancerCare #ASCO2026
ALT Dr. Eric Small delivers the opening talk for ASCO 2026. The slide behind him reads, in English and Spanish: Every patient. Every cancer. Everywhere.
3
7
444
CSO at ASCO: Value, Access, and Quality Care: Can We Have It All?
Panelists Drs. Ian Tannock, Ajay Aggarwal, Haydeé Verduzco, and Brooke Wilson led an Educational Session at #ASCO2026 about the growing “value crisis” in cancer care, where rising costs, uncertain clinical benefits, and gaps in delivering evidence-based care limit patient access and outcomes.
Value in cancer care must be viewed as patient benefits relative to cost—including not just financial expense, but toxicity, time burden, and impact on quality of life.
Low-value treatments—those with minimal benefit or inappropriate use—carry significant opportunity costs, diverting resources away from more effective care and worsening inequities.
Advancing high-quality oncology care will require reducing low-value interventions, improving quality systems, and aligning drug pricing and treatment decisions with meaningful patient outcomes.
Read the paper for more: ascopubs.org/doi/10.1200/EDB…
#CommonSenseOncology #CancerCare #ASCO2026
ALT Panelists sitting at a long table against a blue curtain background.
5
11
418
CSO at ASCO: Innovation, Evidence, Compassion, and Hope: Delivering Outcomes That Matter.
Panelists Drs. Sam Stevens, Michelle Tregear, Rachel Riechelmann, Christopher Jackson, and Chris Booth led an Education Session at #ASCO2026 about the importance of patient-centred outcomes in cancer care.
Over the past 50 years, cancer care has seen remarkable advances, but in some circumstances the way we measure progress is misaligned with what patients value most.
While there have been important advances in biomedical treatment, systems have not placed enough emphasis on the other core domains of holistic care: compassionate communication, patient empowerment, and psychosocial support.
The authors call for a common-sense approach: an emphasis patient-centered outcomes such as survival, quality of life, and functional well-being across clinical trials, policy, and care delivery.
Meaningful progress in oncology will require aligning innovation, evidence, and health systems with compassionate, equitable care that truly improves patients’ lives.
Read the paper for more: ascopubs.org/doi/full/10.120…
#CommonSenseOncology #CancerCare #ASCO2026
ALT Authors of the ASCO Educational Book paper standing for a group photo at ASCO 2026.
4
19
480
Cancer care and movement: a new economic analysis of the landmark CHALLENGE clinical trial shows that a supervised exercise program after adjuvant chemotherapy not only improves colon cancer patient survival, it also reduces costs to our health system. Adopting exercise as a standard anti-cancer treatment would mean fewer cancer recurrences and improved survival for patients, and lower treatment costs for our health system. Read more in the Toronto Star.
tinyurl.com/pas9fvtr
#CommonSenseOncology #CancerCare
ALT Exercise as anti-cancer treatment. A person running in an urban landscape.
9
15
616
May 28
Now available: listen to A/Prof Abhijit Pal explain how to improve access to clinical trials for individuals from culturally and linguistically diverse backgrounds. Find it on YouTube: tinyurl.com/th7az96n
#CommonSenseOncology #CancerCare
1
5
230
May 28
We're looking forward to seeing you at our ASCO sessions this weekend! For details, see below. 👇
#ASCO2026
May 12
Join CSO at ASCO!
🚨 Are you registered to attend ASCO? Attend CSO’s two exciting educational sessions, in-person or online:
🔵 Value, Access, and Quality Care: Can We Have It All?
Moderated by Dr. Ian Tannock
May 30, 2026 | 4:45 - 6:00 pm CDT
E350 | In-person only
🔵 Innovation, Evidence, Compassion, and Hope: Delivering Outcomes That Matter
Moderated by Dr. Chris Booth
May 31, 2026 | 4:30 - 5:45 pm CDT
S100a | In-person and live stream available
Visit the ASCO 2026 program for details: tinyurl.com/yth9v2j5
#CommonSenseOncology #CancerCare #ASCO2026
ALT Common Sense Oncology at ASCO. Eight profile pictures, from left to right: Drs. Christopher Booth, Rachel Riechelmann, Christopher Jackson, Michelle Tregear, Ian Tannock, Ajay Aggarwal, Haydeé Verduzco-Aguirre, Brooke Wilson.
6
12
670
May 21
Check out Common Sense Oncology's latest open-access ASCO Educational Book article by Drs. Ian Tannock, Ajay Aggarwal, Haydee Verduzco-Aguirre, and Brooke Wilson: "Value, Access, and High-Quality Medical Oncology Care: Can We Have It All?"
tinyurl.com/yk42mju6
#CommonSenseOncology #CancerCare
6
9
776
May 15
Does chest wall radiation therapy after mastectomy still work in the oncology landscape today?
Listen to four experts discuss the SUPREMO trial for the Indian context, now live on YouTube.
▶️ Catch it here: youtu.be/y-gsf8ikwaQ
#CommonSenseOncology #CancerCare
ALT Common Sense Oncology. Supremo Trial India Hub. Drs. Sushil Beriwal, Angela Eapen, Seema Gulia, Shafeek Shamsudeen.
1
3
189
May 14
CSO presents a webinar featuring guest speaker A/Prof Abhijit Pal about improving access to clinical trials for individuals from culturally and linguistically diverse backgrounds. A/Prof Pal is a part of the Australian Centre for Cancer Equity, a partnership between Cancer Institute NSW, Ingham Institute for Applied Medical Research and South Western Sydney Local Health District.
Join us online on May 27, 2026 at 7 pm AEST | 5 am EDT | 10 am BST!
Register on Zoom: tinyurl.com/3fec2k6k
#CommonSenseOncology #CancerCare
4
11
396
May 13
Planning to apply to this position? Make sure to apply before the deadline of Tuesday, May 19th! 🚨
May 11
Common Sense Oncology at Queen's University is hiring a Program Officer!
This position will play a key role in supporting CSO’s Canadian and global projects, and in helping to advance our research, knowledge mobilization, and advocacy initiatives.
This is an exciting opportunity to be part of a passionate team working to spark patient-centred change in our cancer care systems. Because we believe that by working together, we can create a better world for people with cancer and their loved ones.
If this mission is important to you, then come work with us!
Go to the job posting: lnkd.in/e3rh2KTN
#CommonSenseOncology #CancerCare
1
3
632
May 12
Join CSO at ASCO!
🚨 Are you registered to attend ASCO? Attend CSO’s two exciting educational sessions, in-person or online:
🔵 Value, Access, and Quality Care: Can We Have It All?
Moderated by Dr. Ian Tannock
May 30, 2026 | 4:45 - 6:00 pm CDT
E350 | In-person only
🔵 Innovation, Evidence, Compassion, and Hope: Delivering Outcomes That Matter
Moderated by Dr. Chris Booth
May 31, 2026 | 4:30 - 5:45 pm CDT
S100a | In-person and live stream available
Visit the ASCO 2026 program for details: tinyurl.com/yth9v2j5
#CommonSenseOncology #CancerCare #ASCO2026
ALT Common Sense Oncology at ASCO. Eight profile pictures, from left to right: Drs. Christopher Booth, Rachel Riechelmann, Christopher Jackson, Michelle Tregear, Ian Tannock, Ajay Aggarwal, Haydeé Verduzco-Aguirre, Brooke Wilson.
7
15
1,154
May 11
Common Sense Oncology at Queen's University is hiring a Program Officer!
This position will play a key role in supporting CSO’s Canadian and global projects, and in helping to advance our research, knowledge mobilization, and advocacy initiatives.
This is an exciting opportunity to be part of a passionate team working to spark patient-centred change in our cancer care systems. Because we believe that by working together, we can create a better world for people with cancer and their loved ones.
If this mission is important to you, then come work with us!
Go to the job posting: lnkd.in/e3rh2KTN
#CommonSenseOncology #CancerCare
1
4
7
1,406
Check out the latest open-access ASCO Educational Book article by Common Sense Oncology fellow Dr. Sam Stevens and peers: "Innovation, Evidence, Compassion, and Hope: Delivering Outcomes That Matter".
ascopubs.org/doi/full/10.120…
#CommonSenseOncology #CancerCare @MichelleTregear @SamuelXStevens @ASCO
5
12
634
What is the Good Pharma Scorecard?
Listen to Dr. Jennifer E. Miller (@millerbioethics) talk about her work on this initiative to rank companies on specific bioethics and patient-centricity critera. Visit the Common Sense Oncology podcast, now available on your favourite streaming platforms:
Spotify: tinyurl.com/2atejx55
Apple Podcasts: tinyurl.com/5jxcv2ee
#CommonSenseOncology #CancerCare
2
5
439
Apr 28
Cancer treatment delivery and outcomes are shaped by the results of clinical trials.
That's why it's important to ensure trials remain unbiased and focused on answering clinical questions that matter most.
@EORTC (European Organisation for Research and Treatment of Cancer) has published a new paper in @TheLancetOncol today highlighting international agreement on the fundamental nature of academic clinical trials. While becoming less common in today's research landscape, these academic trials intrinsically prevent bias.
Common Sense Oncology agrees with the Comment published in The Lancet Oncology and looks forward to the publication of the dedicated Commission.
#CommonSenseOncology #CancerCare
📢 New publication: Academic clinical cancer trials as public good
Read how independent research improves patient outcomes and strengthens healthcare systems.
With contributions from Denis Lacombe (EORTC), Winette van der Graaf and Martin Stockler.
👉 eortc.org/blog/2026/04/28/in…
3
8
713
Apr 27
Join CSO India online for a stimulating discussion about CSO principles and the SUPREMO (chest wall radiation therapy after mastectomy) trial!
When: Wednesday, May 13, 2026, 7-8 pm IST
Register on Zoom: tinyurl.com/bdd4hj3k
#CancerCare #CommonSenseOncology
ALT Common Sense Oncology India Hub. Journal Club: SUPREMO Trial. Wednesday, May 13, 2026, at 7-8 pm IST. Panelists: Dr. Sushil Beriwal, Dr. Shafeek Shamsudeen, Dr. Angela Eapen, and Dr. Seema Gulia. Join us online for a stimulating discussion about CSO principles and the SUPREMO (chest wall radiation therapy after mastectomy) trial.
3
9
477
Apr 24
🚨 Final call to participate in this research initiative! The survey closes in the coming week.
Calling all oncologists, patients, families, and caregivers. Common Sense Oncology needs 10 minutes of your time to help ensure future patients with cancer receive the information they need to make the treatment decisions that are right for them.
CSO and global partners are working to create a short list of questions that patients may find useful when meeting with their oncologist. This anonymous web-based survey takes less than 10 minutes to complete and is approved by the @queensu Queen's University Health Sciences and Affiliated Teaching Hospitals Research Ethics Board (HSREB).
Data from this study will be used to generate a tool that can be used by doctors and patients to help people with cancer get the information they need to make the treatment decisions that are best for them.
Take the survey: tinyurl.com/ywxmms4u
#CommonSenseOncology #CancerCare
ALT Text reads: Navigating a cancer diagnosis is complex. 10 minutes of your time could help empower patients. Pictured: a doctor provides care to a patient. Common Sense Oncology, Queen’s University, and CDA-AMC logos.
3
4
865
Apr 23
Is Common Sense Oncology relevant to cancer care in low and middle income countries?
In this podcast episode, Dr. Fidel Rubagumya shares the improvements Rwanda has made to its cancer care system, showcasing how LMICs can adopt CSO principles to work towards equitable coverage in cancer care.
Listen on Spotify: tinyurl.com/2439wr77
Listen on Apple Podcasts: tinyurl.com/yk2by8ab
@Rubagumyaf
#CommonSenseOncology #CancerCare
4
10
624